Charles Schwab’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Charles Schwab’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-155,534	Closed	-$1.91M	–	3624
2022 Q4	$1.91M	Buy	155,534 +17,330	+13%	+$413K	﹤0.01%	2584
2022 Q3	$4.54M	Buy	138,204 +46,923	+51%	+$1.33M	﹤0.01%	2261
2022 Q2	$1.72M	Buy	91,281 +2,394	+3%	+$45.8K	﹤0.01%	2615
2022 Q1	$1.56M	Buy	+88,887	New	+$1.82M	﹤0.01%	2726

Charles Schwab's CINC Position: Q1 2023 in Review

Charles Schwab sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 155,534 shares — an estimated $1.91M sold.

Charles Schwab first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $4.54M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Charles Schwab reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Charles Schwab sold 155,534 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.91M.
Charles Schwab first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Charles Schwab's CinCor Pharma, Inc. Common Stock position peaked at $4.54M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.